Deferasirox, dalfampridine
Ended Awarded
- Contract number
- VA69D607P10112
- Awardee
-
Novartis Pharmaceuticals Corporation UEI NG61ZA8TADW3
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $20,153
Award facts
- Contract value 100% obligated
- $20,153.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53705, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract VA69D607P10112?
VA69D607P10112 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 12 (Veterans Health Administration) on July 13, 2011.
How much is contract VA69D607P10112 worth?
The government has obligated $20,153 on VA69D607P10112.
Is contract VA69D607P10112 an order under another contract?
Yes. VA69D607P10112 is a delivery order under V797P5879X, a federal supply schedule.
Was contract VA69D607P10112 competed?
The extent of competition for VA69D607P10112 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award